New data show Lilly's Trulicity in combination with an SGLT-2 inhibitor improves blood sugar control in type 2 diabetics | RSS News Feed

New data show Lilly's Trulicity in combination with an SGLT-2 inhibitor improves blood sugar control in type 2 diabetics - Latest News

RSS Feed for this news: New data show Lilly's Trulicity in combination with an SGLT-2 inhibitor improves blood sugar control in type 2 diabetics

New Data Show Lilly's Trulicity® (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes

INDIANAPOLIS, Feb. 26, 2018 /PRNewswire/ -- Trulicity ® (dulaglutide) significantly improves A1C (average blood sugar concentration ... 2 (SGLT-2) inhibitor, according to results from AWARD-10, a new Phase 3b clinical study. 1 These data were published ... read more

New Data Show Lilly's Trulicity® (dulaglutide) in Combination wi - KPTV - FOX 12

INDIANAPOLIS, Feb. 26, 2018 /PRNewswire/ -- Trulicity ® (dulaglutide) significantly improves A1C (average blood sugar concentration ... 2 (SGLT-2) inhibitor, according to results from AWARD-10, a new Phase 3b clinical study. 1 These data were published ... read more

New data show Lilly's Trulicity in combination with an SGLT-2 inhibitor improves blood sugar control in type 2 diabetics

... superior glycemic control compared to an SGLT-2 inhibitor with placebo. Trulicity is once-weekly, injectable glucagon-like peptide-1 (GLP-1) receptor agonist approved to improve blood sugar (glucose) in adults with type 2 diabetes. Trulicity should be ... read more


FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us